Compile Data Set for Download or QSAR
Report error Found 530 Enz. Inhib. hit(s) with all data for entry = 2641
TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127782BDBM127782(US8791123, 155 | US9782415, Example 155 | US979672...)
Affinity DataIC50: 0.200nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344316BDBM344316(US9782415, Example 25 | US9796724, Example 25 | US...)
Affinity DataIC50: 0.400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127634BDBM127634(US8791123, 7 | US9782415, Example 7 | US9796724, E...)
Affinity DataIC50: 0.450nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127640BDBM127640(US8791123, 13 | US9782415, Example 13 | US9796724,...)
Affinity DataIC50: 0.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127641BDBM127641(US8791123, 14 | US9782415, Example 14 | US9796724,...)
Affinity DataIC50: 0.550nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127693BDBM127693(US8791123, 66 | US9782415, Example 66 | US9796724,...)
Affinity DataIC50: 0.570nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127647BDBM127647(US8791123, 20 | US9782415, Example 20 | US9796724,...)
Affinity DataIC50: 0.600nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127642BDBM127642(US8791123, 15 | US9782415, Example 15 | US9796724,...)
Affinity DataIC50: 0.600nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127692BDBM127692(US8791123, 65 | US9782415, Example 65 | US9796724,...)
Affinity DataIC50: 0.600nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344339BDBM344339(US9782415, Example 48 | US9796724, Example 48 | US...)
Affinity DataIC50: 0.600nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344330BDBM344330(US9782415, Example 39 | US9796724, Example 39 | US...)
Affinity DataIC50: 0.700nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127628BDBM127628(US8791123, 1 | US9782415, Example 1 | US9796724, E...)
Affinity DataIC50: 0.700nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127629BDBM127629(US8791123, 2 | US9782415, Example 2 | US9796724, E...)
Affinity DataIC50: 0.700nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127667BDBM127667(US8791123, 40 | US9782415, Example 40 | US9796724,...)
Affinity DataIC50: 0.800nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127767BDBM127767(US8791123, 140 | US9782415, Example 140 | US979672...)
Affinity DataIC50: 0.900nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127796BDBM127796(US8791123, 169 | US9782415, Example 169 | US979672...)
Affinity DataIC50: 0.900nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127767BDBM127767(US8791123, 140 | US9782415, Example 140 | US979672...)
Affinity DataIC50: 0.900nMAssay Description:Trk enzymatic selectivity was assessed using Omnia Kinase Assay reagents from Invitrogen Corp. Enzyme (either TrkA or TrkB from Invitrogen Corp.) and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127643BDBM127643(US8791123, 16 | US9782415, Example 16 | US9796724,...)
Affinity DataIC50: 0.900nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127632BDBM127632(US8791123, 5 | US9782415, Example 5 | US9796724, E...)
Affinity DataIC50: 0.950nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127631BDBM127631(US8791123, 4 | US9782415, Example 4 | US9796724, E...)
Affinity DataIC50: 0.950nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127717BDBM127717(US8791123, 90 | US9782415, Example 90 | US9796724,...)
Affinity DataIC50: 0.950nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344346BDBM344346(US9782415, Example 55 | US9796724, Example 55 | US...)
Affinity DataIC50: 1nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127637BDBM127637(US8791123, 10 | US9782415, Example 10 | US9796724,...)
Affinity DataIC50: 1.05nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127650BDBM127650(US8791123, 23 | US9782415, Example 23 | US9796724,...)
Affinity DataIC50: 1.10nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127775BDBM127775(US8791123, 148 | US9782415, Example 148 | US102518...)
Affinity DataIC50: 1.10nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127635BDBM127635(US8791123, 8 | US9782415, Example 8 | US9796724, E...)
Affinity DataIC50: 1.10nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127792BDBM127792(US8791123, 165 | US9782415, Example 165 | US979672...)
Affinity DataIC50: 1.10nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344325BDBM344325(US9782415, Example 34 | US9796724, Example 34 | US...)
Affinity DataIC50: 1.10nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344372BDBM344372(US9782415, Example 81 | US9796724, Example 81 | US...)
Affinity DataIC50: 1.15nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127677BDBM127677(US8791123, 50 | US9782415, Example 51 | US9796724,...)
Affinity DataIC50: 1.18nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127662BDBM127662(US8791123, 35 | US9782415, Example 35 | US9796724,...)
Affinity DataIC50: 1.20nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127795BDBM127795(US8791123, 168 | US9796724, Example 168 | US102518...)
Affinity DataIC50: 1.20nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127677BDBM127677(US8791123, 50 | US9782415, Example 51 | US9796724,...)
Affinity DataIC50: 1.23nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127656BDBM127656(US8791123, 29 | US9782415, Example 29 | US9796724,...)
Affinity DataIC50: 1.30nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344370BDBM344370(US9782415, Example 79 | US9796724, Example 79 | US...)
Affinity DataIC50: 1.30nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127781BDBM127781(US8791123, 154 | US9782415, Example 154 | US979672...)
Affinity DataIC50: 1.30nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344329BDBM344329(US9782415, Example 38 | US9796724, Example 38 | US...)
Affinity DataIC50: 1.30nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127653BDBM127653(US8791123, 26 | US9782415, Example 26 | US9796724,...)
Affinity DataIC50: 1.30nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344336BDBM344336(US9782415, Example 45 | US9796724, Example 45 | US...)
Affinity DataIC50: 1.40nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127778BDBM127778(US8791123, 151 | US9782415, Example 151 | US979672...)
Affinity DataIC50: 1.40nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344335BDBM344335(US9782415, Example 44 | US9796724, Example 44 | US...)
Affinity DataIC50: 1.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344338BDBM344338(US9782415, Example 47 | US9796724, Example 47 | US...)
Affinity DataIC50: 1.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344324BDBM344324(US9782415, Example 33 | US9796724, Example 33 | US...)
Affinity DataIC50: 1.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127800BDBM127800(US8791123, 173 | US9782415, Example 173 | US979672...)
Affinity DataIC50: 1.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127633BDBM127633(US8791123, 6 | US9782415, Example 6 | US9796724, E...)
Affinity DataIC50: 1.55nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127691BDBM127691(US8791123, 64 | US9782415, Example 64 | US9796724,...)
Affinity DataIC50: 1.60nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127664BDBM127664(US8791123, 37 | US9782415, Example 37 | US9796724,...)
Affinity DataIC50: 1.65nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127757BDBM127757(US8791123, 130 | US9782415, Example 130 | US979672...)
Affinity DataIC50: 1.70nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 127835BDBM127835(US8791123, 208 | US9782415, Example 208 | US979672...)
Affinity DataIC50: 1.70nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Array Biopharm

US Patent
LigandChemical structure of BindingDB Monomer ID 344374BDBM344374(US9782415, Example 83 | US9796724, Example 83 | US...)
Affinity DataIC50: 1.77nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

Displayed 1 to 50 (of 530 total ) | Next | Last >>
Jump to: